Close Menu

NEW YORK (360Dx) – Medicortex Finland announced on Tuesday a deal with Pro-Lab Diagnostics aimed at commercializing Medicortex's brain injury detection kit in Canada and the UK.

Under the terms of the agreement Pro-Lab will shepherd the kit through the regulatory processes in Canada and the UK, as well as be responsible for clinical validation of the kit. Medicortex has granted Pro-Lab exclusive rights to sell the test in Canada and the UK in return for royalties.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.